Enhancement of cisplatin activity by lonidamine in human ovarian cancer cells
Rosella Silvestrini(Fondazione IRCCS Istituto Nazionale dei Tumori), Aurora Costa, L. Orlandi(Fondazione IRCCS Istituto Nazionale dei Tumori), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Raffaella Villa(IRCCS Policlinico San Donato)
Cited by 41
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
|Cellular and Molecular Life Sciences|2002|274